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Abstract. 
 
The SR superfamily of splicing factors and 
regulators is characterized by arginine/serine (RS)-rich 
domains, which are extensively modiﬁed by phosphory-
lation in cells. In vitro binding studies revealed that RS 
domain–mediated protein interactions can be differen-
tially affected by phosphorylation. Taking advantage of 
the single nonessential SR protein–speciﬁc kinase 
Sky1p in 
 
Saccharomyces
 
 
 
cerevisiae
 
,
 
 
 
we investigated RS 
domain interactions in vivo using the two-hybrid assay. 
Strikingly, all RS domain–mediated interactions were 
abolished by 
 
SKY1
 
 deletion and were rescuable by 
yeast or mammalian SR protein–speciﬁc kinases, indi-
cating that phosphorylation has a far greater impact on 
RS domain interactions in vivo than in vitro. To under-
stand this dramatic effect, we examined the localization 
of SR proteins and found that SC35 was shifted to the 
 
cytoplasm in 
 
sky1
 
D
 
 yeast, although this phenomenon 
was not obvious with ASF/SF2, indicating that nuclear 
import of SR proteins may be differentially regulated 
by phosphorylation. Using a transcriptional repression 
assay, we further showed that most LexA-SR fusion 
proteins depend on Sky1p to efﬁciently recognize the 
LexA binding site in a reporter, suggesting that molecu-
lar targeting of RS domain–containing proteins within 
the nucleus was also affected. Together, these results re-
veal multiple phosphorylation-dependent steps for SR 
proteins to interact with one another efﬁciently and 
speciﬁcally, which may ultimately determine the splic-
ing activity and speciﬁcity of these factors in mamma-
lian cells.
Key words: SR proteins • SRPK1 • SRPK2 • Clk • 
Sty • RS domains
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-mRNA splicing takes place in an RNA machine
known as the spliceosome, which consists of small
nuclear ribonucleoprotein particles (snRNPs)
 
1
 
 and
non-snRNP protein factors. The RNA components in the
spliceosome form the catalytic core through a series of dy-
namic RNA–RNA interactions which are likely to be me-
diated and/or stabilized by non-snRNP protein factors (for
recent reviews see Nilsen, 1998; Staley and Guthrie, 1998).
Among the best characterized non-snRNP splicing factors
are SR proteins which contain one or two RNA recogni-
tion motifs and a signature RS domain containing multiple
serine and arginine repeats (for reviews see Fu, 1995;
Manley and Tacke, 1996). The RNA recognition motifs
bind to RNA sequences in a coordinated fashion to deter-
mine splicing specificity (Chandler et al., 1997) and com-
mit pre-mRNA substrates to the splicing pathway (Fu,
1993), whereas the RS domains mediate specific protein–
protein interactions in a number of spliceosomal assembly
steps (Wu and Maniatis, 1993; Kohtz et al., 1994; Roscigno
and Garcia-Blanco, 1995; Tronchère et al., 1997). In fact,
the RS domain is present in a large number of proteins,
many of which are proven splicing factors and/or regula-
tors (for review see Fu, 1995).
SR proteins are especially interesting because their
functions in splice site selection and spliceosome assembly
appear to be regulated by phosphorylation. In vitro, phos-
phorylation of RS domains can enhance the interactions
between RS domain–containing proteins (Xiao and Man-
ley, 1997; Wang et al., 1998) and prevent their nonspecific
binding to RNA (Tacke et al., 1997), which may explain
the requirement of phosphorylated SR proteins to initiate
spliceosome assembly at early steps (Mermoud et al., 1994;
Cao et al., 1997). On the other hand, dephosphorylation
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1. 
 
Abbreviation used in this paper:
 
 snRNPs, small nuclear ribonucleopro-
tein particles. 
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appears to be required for the resolution of the spliceo-
some to produce spliced products (Tazi et al., 1993; Mer-
moud et al., 1994; Cao et al., 1997). Thus, the phosphoryla-
tion–dephosphorylation cycle of RS domains appears to
accompany, and likely regulate, the splicing cycle.
The impact of phosphorylation on SR protein function
in vivo is further manifested by the localization and intra-
cellular trafficking of splicing factors in mammalian cells.
Most splicing factors are unevenly distributed in the nu-
cleus, giving rise to a speckled appearance in all somatic
animal cells examined to date (for review see Spector,
1993). Although nuclear speckles contain polyadenylated
RNA (Xing et al., 1993) and are associated with some ac-
tively transcribing genes (Xing et al., 1995), most splicing
reactions appear to take place cotranscriptionally in the
nucleoplasm and, therefore, splicing factors need to be re-
cruited to sites of transcription (Misteli et al., 1997, 1998).
Importantly, this intranuclear movement of splicing fac-
tors appears to be mediated by RS domain phosphoryla-
tion (Gui et al., 1994a; Colwill et al., 1996a; Cáceres et al.,
1997; Misteli et al., 1997, 1998; Duncan et al., 1998). Be-
cause SR proteins are known to affect splice site selection
in a concentration-dependent manner, such phosphoryla-
tion-dependent localization of splicing factors among dif-
ferent nuclear pools may be a mechanism to regulate alter-
native splicing. Indeed, it was demonstrated recently that
alternative splicing in vivo can be modulated by phos-
phorylation, presumably through modifying SR proteins
(Duncan et al., 1997; Kanopka et al., 1998). These obser-
vations illustrate the importance of understanding the
function and regulation of SR proteins by specific kinases
in cells.
Mammalian cells express several SR protein–specific ki-
nases, of which the best characterized are the SRPK and
Clk/Sty families of kinases (Gui et al., 1994a; Colwill et al.,
1996ab; Duncan et al., 1998; Kuroyanagi et al., 1998; Wang
et al., 1998). These two kinase families are structurally dis-
tinct, exhibit different substrate specificities, and are dif-
ferentially expressed (Gui et al., 1994b; Colwill et al.,
1996b; Wang et al., 1998). The SRPK and Clk/Sty kinases
are also differentially localized in cells: SRPKs are present
in both the cytoplasm and the nucleus (Wang et al., 1998),
whereas Clk/Sty kinases appear to localize exclusively in
the nucleus (Colwill et al., 1996a; Duncan et al., 1998). The
existence of multiple SR protein kinases with distinct sub-
strate specificity and localization in mammalian cells sug-
gests that RS domain–mediated interactions may be sub-
ject to coordinate regulation by phosphorylation in a
temporal- and spatial-specific manner. Therefore, it is im-
portant to study phosphorylation regulation of pre-mRNA
splicing at both the biochemical and cellular levels.
In this study, we established a novel model system using
 
Saccharomyces cerevisiae
 
 to investigate the importance of
phosphorylation in RS domain–mediated protein–protein
interactions in vivo. Unlike mammalian cells that express
many SR protein kinases, budding yeast express only a sin-
gle conserved SR protein–specific kinase, Sky1p, which
was cloned and characterized recently in our lab (Siebel et
al., 1999). Structural and functional studies demonstrate
that Sky1p is a SRPK family member that has the same
high activity and specificity for mammalian SR proteins as
SRPK1 and SRPK2. Moreover, increasing evidence sug-
 
gests that budding yeast express proteins that are structur-
ally and functionally related to mammalian RS domain–
containing proteins. Therefore, yeast provide a powerful
genetic system to study SR protein function in vivo, which
will provide clues to the function and regulation of SR
proteins in mammalian cells. Here, we took advantage of
the fact that 
 
SKY1
 
 is not essential for vegetative growth in
yeast. Therefore, we were able to express mammalian RS
domain–containing proteins and study their interactions in
cells with and without SRPK-mediated phosphorylation,
an approach that was not possible in mammalian cells. Our
results demonstrate that RS domain–mediated protein–
protein interactions in vivo are entirely dependent on the
activity of Sky1p, which can be substituted by SRPK1 or
Clk/Sty from mammalian cells. Further examination of RS
domain interactions in this system reveal that, in addition
to the modulation of protein affinities, SRPKs appear to
play an important role in mediating nuclear import of SR
proteins as well as in finding their targets within the nu-
cleus.
 
Materials and Methods
 
In Vitro Binding
 
GST pull-down assays were performed as described (Wang et al., 1998).
Bacterially expressed GST-ASF/SF2 (100 
 
m
 
g) was phosphorylated in vitro
using baculovirus-expressed GST-SRPK1 (10 U, see Gui et al., 1994b) for
6 h at 30
 
8
 
C with or without 1 mM ATP. Proteins were desalted on G-50
columns (Pharmacia) and rebound to glutathione beads before binding to
TNT (Promega) translated U1-70K or U2AF35. Empty beads or GST-
loaded beads were used as controls.
 
Two-Hybrid Interactions
 
Two-hybrid assays were performed as described using the LexA system
(Gyuris et al., 1993; Wu and Maniatis, 1993). Strain EGY48 was deleted of
the 
 
SKY1
 
 gene by recombination with a kanamycin resistance expression
unit flanked by 
 
SKY1
 
 genomic sequences (Wach et al., 1994). The dele-
tion encompassed 316 bp 5
 
9
 
 of the initiation codon to 541 bp 5
 
9
 
 of the ter-
mination codon, and was confirmed by PCR. Bait and prey plasmids were
gifts from J. Wu (Wu and Maniatis, 1993) or were constructed in pEG202
and pJG4-5 with modified polylinkers (Wang et al., 1997). Expressed pro-
teins were verified by Western blotting with a monoclonal anti-LexA anti-
body (Clontech) using the enhanced chemiluminescent detection system
(Pierce) in conjunction with HRP-labeled goat anti–mouse antibodies. Ki-
nase expression plasmids were constructed in p415GAL1 (Mumberg et al.,
1994) for selecting Leu
 
1
 
 phenotype (Wu and Maniatis, 1993). Deletions of
the RS domains in U2AF65 (residues 1–65) and U2AF35 (residues 191–
240) were made by PCR. 
 
b
 
-Galactosidase activity is expressed as Miller
units: OD420 
 
3
 
 1,000/OD600 
 
3
 
 time (min) 
 
3
 
 culture volume assayed
(ml), determined at 30
 
8
 
C.
 
Immunolocalization
 
Freshly streaked yeast clones bearing prey plasmids (HA tagged) were in-
oculated in 5 ml YPGal/Raff and grown for 3 h at 30
 
8
 
C. Yeast were fixed
with 0.7 ml 37% formaldehyde and processed for immunofluorescence as
described (McConnell et al., 1990), using the 12CA5 antibody at 1:100.
 
GFP-ASF/SF2 Expression
 
Humanized GFP (pGreenLantern-1; Life Technologies) was fused in
frame to the NH
 
2
 
 terminus of ASF/SF2 wild-type cDNA or the KS substi-
tution mutant (Cáceres and Krainer, 1993). The fusion protein was ex-
pressed from pcDNA3 (Invitrogen) in HeLa cells for 48 h before visual-
ization of live cells. Whole cell extracts (200 
 
m
 
g) were treated with 500 U
CIP (Boehringer Mannheim; Misteli et al., 1998) and subjected to West-
ern analysis using an anti-GFP antibody (Chemicon). 
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Transcriptional Repression
 
Both the parent EGY48 and corresponding 
 
sky1
 
D
 
 strains were grown on
5-FOA plates to eliminate the pSH18-24 two-hybrid reporter (lacZ) plas-
mid. The resulting strains were cotransformed with pEG202-based bait
plasmids and pJK101, a transcriptional repression reporter (Golemis and
Brent, 1992), then assayed for 
 
b
 
-galactosidase activity. Maximal transcrip-
tion was determined using a modified bait plasmid lacking LexA.
 
Results
 
Differential Modulation of RS Domain Interactions
In Vitro
 
Phosphorylation of the SR protein ASF/SF2 by SRPK1,
SRPK2, or Clk/Sty has been shown previously to enhance
its interaction in vitro with the U1 snRNP-specific 70-kD
protein (U1-70K) in a GST pull-down assay (Xiao and
Manley, 1997; Wang et al., 1998; Fig. 1). This enhancement
may result from the neutralization of charges, allowing RS
domains to interact efficiently (Xiao and Manley, 1997).
To test the generality of this principle, we examined the
effect of SRPK1-mediated phosphorylation on ASF/SF2
binding to another RS domain–containing splicing factor,
U2AF35, an interaction proposed for pairing the 5
 
9
 
 and
3
 
9
 
 splice sites (Wu and Maniatis, 1993). Unexpectedly,
binding of unphosphorylated ASF/SF2 to U2AF35 was
readily detectable, and this interaction was largely un-
affected by SRPK1-mediated phosphorylation (Fig. 1).
These results indicate that phosphorylation differentially
modulates the affinity between RS domain–containing
splicing factors, depending on the pairs examined. A sim-
ilar observation was also made independently by Xiao
and Manley (1998).
 
Detection of Phosphorylation-dependent Interactions 
In Vivo
 
To examine the role of phosphorylation in protein–protein
interactions under physiological conditions, we took ad-
vantage of the single conserved SR protein–specific kinase
in 
 
S
 
.
 
 cerevisiae
 
 to investigate RS domain interactions in the
presence or absence of phosphorylation. Mammalian SR
proteins expressed in both wild-type and 
 
SKY1
 
 deletion
(
 
sky1
 
D
 
) yeast strains were soluble, but differed in their
phosphorylation states, as determined by mobility shift on
SDS-PAGE as well as Western blotting with mAb 104,
a monoclonal antibody specific for the phosphoepitope
present in all SR proteins (data not shown; Siebel et al.,
1999). As shown in Fig. 2 a, LexA-ASF/SF2 and LexA-
SC35 expressed in wild-type yeast migrated more slowly
than those from 
 
sky1
 
D
 
 yeast (left four lanes), indicative of
a change in phosphorylation states (see Xiao and Manley,
1997). Reexpression of Sky1p, but not an ATP binding site
mutant (Sky1p K187M), restored the phosphorylated form
of ASF/SF2 (right two lanes). Therefore, Sky1p appears to
be the only endogenous kinase capable of efficiently phos-
phorylating mammalian SR proteins expressed in yeast.
This system offers a unique opportunity to test the phos-
Figure 1. SRPK1-mediated phosphorylation differentially modu-
lates the affinity of RS domain interactions in vitro. In a GST
pull-down assay, mock-phosphorylated (2ATP) or SRPK1-
treated GST-ASF/SF2 (1ATP) were bound to 35S-labeled, in
vitro translated U1-70K (left four lanes) or U2AF35 (right four
lanes) followed by analysis on SDS-PAGE. Coomassie-stained
bands are shown in the top panel to illustrate the mobility shift
due to phosphorylation, and the lower panel shows an autoradio-
graph of the same gel. A band above the U1-70K could be a mod-
ified form of U1-70K because it is only present in U1-70K RNA-
programmed in vitro translation reactions.
Figure 2. RS domain interactions in vivo require phosphoryla-
tion. (a) Western blotting analysis of LexA-SC35 and LexA-
ASF/SF2 expressed in wild-type or sky1D S. cerevisiae (left four
lanes). Whole cell yeast extracts were probed with anti-LexA an-
tibodies. The right two lanes show extracts from sky1D yeast co-
expressing ASF/SF2 with Sky1p or an ATP binding site mutant,
Sky1p K187M. (b) Two-hybrid analysis of protein–protein inter-
actions in wild-type and sky1D yeast. Baits are listed on the left
and preys are listed across. Data are expressed as fold over back-
ground using the empty prey vector in wild-type versus mutant
yeast. 
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phorylation dependence of RS domain interactions in vivo
using the two-hybrid strategy.
The results of two-hybrid assays are shown in Fig. 2 b.
As a control, the interaction between the nuclear receptor
transcription factor T3R and its corepressor NCoR, which
are not SRPK1 substrates (data not shown), was unaf-
fected by the 
 
SKY1
 
 deletion. In contrast, the interactions
between RS domain–containing splicing factors, all SRPK
substrates, were largely eliminated in 
 
sky1
 
D
 
 yeast. Growth
assays of these interactions agreed with the quantitative
assays (data not shown). In particular, RS domain–medi-
ated interactions between U1-70K and either ASF/SF2 or
SC35 were completely abolished in 
 
sky1
 
D
 
 yeast, consistent
with the in vitro binding data. As expected, the interaction
between ASF/SF2 or SC35 with U2AF35 was detectable in
wild-type yeast, but we never detected any interaction be-
tween these three RS domain–containing splicing factors
in parallel experiments in 
 
sky1
 
D
 
 yeast. Surprisingly, the
two-hybrid interaction between U2AF65 and U2AF35
was also severely affected by the 
 
SKY1
 
 deletion, despite
the fact that their interaction takes place outside their RS
domains
 
 
 
(Zhang et al., 1992; see below). These results
clearly indicate that phosphorylation has a far greater im-
pact on RS domain interactions in vivo than in vitro, re-
flecting additional phosphorylation-dependent events for
the interaction between RS domain proteins in cells.
 
Functional Rescue by Yeast and Mammalian SR 
Protein Kinases
 
To further demonstrate that Sky1p-mediated phosphory-
lation is critical for RS domain–containing proteins to in-
teract with one another, we conducted kinase rescue ex-
periments. As shown in Table I, Sky1p, but not its ATP
binding site mutant, was able to restore the two-hybrid in-
teractions examined, proving that Sky1p kinase activity is
required. Because mammalian cells express more than one
kinase family for SR proteins, the yeast model system pro-
vides an opportunity to evaluate functional similarities be-
tween different mammalian SR protein–specific kinases.
Therefore, we extended the rescue experiments to SRPK1
and Clk/Sty from mammalian cells. As shown in Table I,
both SRPK1 and Clk/Sty, but not corresponding ATP
binding site mutants, were able to restore the interactions
of U1-70K with both ASF/SF2 and SC35. In contrast, an
unrelated kinase, the catalytic subunit of protein kinase A,
did not rescue these interactions. Therefore, kinases from
both the SRPK and Clk/Sty families appear to be function-
ally equivalent in this assay. The restoration of these
two-hybrid interactions by different SR protein kinases
strongly argues against the possibility that the lack of RS
domain–mediated interactions in 
 
sky1
 
D
 
 yeast is due to a
general defect resulting from the 
 
SKY1
 
 deletion. Further-
more, the ability of Clk/Sty to restore the two-hybrid inter-
actions in 
 
sky1
 
D
 
 yeast implies that there may be no endog-
enous kinase with the same activity and specificity as Clk/
Sty in 
 
S
 
. 
 
cerevisiae
 
, whereas mammalian cells have evolved
multiple SR protein kinases to regulate RS domain–con-
taining splicing factors.
 
Nuclear Localization of SC35 Affected by
SKY1 Deletion
 
The absolute dependence of RS domain–mediated inter-
actions in vivo on phosphorylation is in sharp contrast to
the affinity changes modulated by phosphorylation in
vitro. This difference raises the possibility that other as-
pects of SR protein function may be affected by phosphor-
ylation in vivo and, therefore, offers an opportunity to in-
vestigate additional phosphorylation-dependent events.
For instance, hypophosphorylated SR proteins may be se-
questered in the nucleus due to nonspecific binding to
other proteins or nucleic acids, as suggested by in vitro
RNA binding studies (Tacke et al., 1997; Xiao and Man-
ley, 1997). Therefore, we examined the localization of ex-
pressed SR proteins in yeast by immunohistochemistry. As
shown in Fig. 3, SC35 expressed from the prey vector was
largely localized in the nucleus in wild-type yeast, but dis-
persed uniformly in both the cytoplasm and the nucleus in
 
sky1
 
D
 
 yeast. In other experiments using a prey vector lack-
ing an exogenous nuclear localization signal, SC35 was
uniformly distributed in wild-type cells, but excluded from
the nucleus in 
 
sky1
 
D
 
 yeast, leaving a “hole” in the immu-
nofluorescence image (data not shown). These unantici-
pated findings suggest that Sky1p-mediated phosphoryla-
tion may regulate nuclear import of SC35 expressed in
yeast. However, the localization of ASF/SF2, U1-70K, and
U2AF35 seemed mostly unaffected by the 
 
SKY1
 
 deletion
as they were generally uniformly distributed in both the
nucleus and cytoplasm of wild-type and 
 
sky1
 
D
 
 yeast (Fig. 3
and data not shown). These observations suggest for the
first time that SRPK-mediated phosphorylation plays an
important role in nuclear import of SR proteins, although
not all SR proteins are affected in the same way.
To obtain further evidence that SRPK-mediated phos-
phorylation plays a role in nuclear localization of RS do-
main proteins in mammalian cells, we took advantage of
the KS substitution mutant of ASF/SF2 in which arginines
in the RS domain are replaced by lysines (Cáceres and
Krainer, 1993). We have shown previously that ASF/SF2-
KS is not a substrate for the SRPK family of kinases, but
can be phosphorylated by Clk/Sty (Colwill et al., 1996b).
Consistent with the observation that there appears to be
no Clk/Sty-like kinase activity in yeast, ASF/SF2-KS did
not interact with U1-70K in the two-hybrid assay even in
wild-type yeast (data not shown). We expressed wild-type
ASF/SF2 and ASF/SF2-KS as GFP fusion proteins in
 
Table I. SR Protein–specific Kinase Rescue of
Two-Hybrid Interactions
 
Strain Kinase expressed SC35:U1-70K ASF/SF2:U1-70K
 
SKY1
 
None 100 100
 
sky1
 
D
 
None 0 0
 
sky1
 
D
 
Sky1p 43 35
 
sky1
 
D
 
Sky1p K187M 0 0
 
sky1
 
D
 
SRPK1 104 100
 
sky1
 
D
 
SRPK1 K109M 0 0
 
sky1
 
D
 
Clk/Sty 86 98
 
sky1
 
D
 
Clk/Sty K 190R 1 2
 
sky1
 
D
 
PKA 1 1
 
b
 
-Galactosidase activities were determined in 
 
SKY1
 
 or in 
 
sky1
 
D
 
 yeast coexpressing
either ASF/SF2 or SC35 and U1-70K in addition to the indicated kinases or mutated
kinase controls. Results are expressed as a percentage of the maximal two-hybrid in-
teraction for each pair. 
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HeLa cells, and expressed proteins were examined for
phosphorylation-dependent mobility shifts on SDS-PAGE
(Fig. 4 a). Treatment with alkaline phosphatase caused an
increase in the mobility of wild-type ASF/SF2, but had no
effect on that of the KS mutant, suggesting that GFP-ASF/
SF2-KS expressed in mammalian cells is not phosphory-
lated. The localization of these proteins in HeLa cells is
shown in Fig. 4 b. Wild-type GFP-ASF/SF2 localized in
the nucleus in a speckled pattern characteristic of endog-
enous splicing factors. In contrast, GFP-ASF/SF2-KS
showed significant accumulation in the cytoplasm. ASF/
SF2-KS was also localized in the nucleus in enlarged
speckles, which is consistent with a role of SRPKs in disso-
ciating splicing factors from nuclear speckles, as suggested
earlier (Gui et al., 1994a). These observations reinforce
the idea that SRPK-mediated phosphorylation plays an
important role in both nuclear import and intranuclear lo-
calization of SR proteins.
Figure 3. Localization of SR
proteins in yeast is differentially
affected by Sky1p-mediated
phosphorylation. HA-tagged
SC35 or ASF/SF2 was expressed
from the prey vector in wild-type
or  sky1D yeast. The expressed
proteins were detected with a
monoclonal antibody (12CA5)
followed by rhodamine-labeled
goat anti–mouse antibodies (left
panels); yeast DNA was stained
with DAPI (right panels).
Figure 4. Evidence for a role of SRPK-mediated phosphorylation in ASF/SF2 lo-
calization in mammalian cells. (a) Whole cell extracts of GFP-ASF/SF2 wild-type
or GFP-ASF/SF2-KS expressed in HeLa cells were either mock (2) or phos-
phatase (1) treated, then probed with an antibody to GFP. (b) Wild-type GFP-
ASF/SF2 (left) or mutant GFP-ASF/SF2 KS (right) fusion proteins were ex-
pressed and visualized in live HeLa cells. 
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Evidence for Phosphorylation-dependent Molecular 
Targeting in the Nucleus
 
Although inefficient nuclear localization may be a contrib-
uting factor for impaired protein–protein interactions
involving SC35, it cannot explain the absolute phosphory-
lation dependence of all the RS domain–mediated interac-
tions we tested in 
 
sky1
 
D
 
 yeast. Furthermore, the two-hybrid
interaction between U2AF65 and U2AF35 in 
 
sky1
 
D
 
 yeast
was also substantially reduced (Fig. 2 b) despite the fact
that this interaction is not RS domain–mediated (Zhang et
al., 1992). When the RS domains of U2AF65 and U2AF35
were deleted, their two-hybrid interaction became highly
efficient in both wild-type and 
 
sky1
 
D
 
 yeast, even surpass-
ing the interaction between full-length proteins in wild-
type yeast (Table II). These observations suggest that the
phosphorylation state of their RS domains may influ-
ence the U2AF65-35 interaction in eukaryotic cells, even
though this interaction can take place in bacteria (Rudner
et al., 1998). In an attempt to correlate inefficient two-
hybrid interactions with a defect in heterodimer formation
between U2AF65 and U2AF35, we conducted gel filtra-
tion and coimmunoprecipitation experiments and de-
tected similar amounts of U2AF65 and 35 in large protein
complexes from both wild-type and 
 
sky1
 
D
 
 yeast (data not
shown). Because these complexes may contain additional
proteins, we cannot determine whether phosphorylation
directly affects the efficiency of heterodimer formation.
Alternatively, Sky1p may indirectly affect the outcome of
the two-hybrid interaction assay by regulating molecular
targeting of its substrates to each other and/or to the re-
porter gene in the nucleus.
To demonstrate that SRPKs play a direct role in assist-
ing RS domain–containing proteins to locate their specific
protein or RNA targets, we adapted the following tran-
scriptional repression assay (Golemis and Brent, 1992),
which allowed a quantitative measure of phosphorylation-
dependent molecular targeting of RS domain proteins in
vivo. As diagrammed in Fig. 5, LexA operators were in-
serted between a GAL1 upstream activating sequence
(UAS) and the transcriptional start site for lacZ such that
LexA or LexA fusion proteins bind to the operators and
repress lacZ expression. In both wild-type and 
 
sky1
 
D
 
yeast, lacZ expression was constitutive in the absence of
LexA, and repressed in its presence. The ability of a con-
trol LexA-T3R fusion protein to repress lacZ expression
was not affected by the 
 
SKY1
 
 deletion. In contrast, the tar-
geting of LexA-SR fusion proteins was dramatically, al-
though not equally, affected by the 
 
SKY1
 
 deletion in this
assay (Fig. 5). In particular, the LexA-SC35 fusion protein
fully repressed lacZ expression in wild-type yeast, but
showed little repression in 
 
sky1
 
D
 
 yeast, probably reflecting
the significant impact of Sky1p-mediated phosphorylation
on the fusion protein at both nuclear localization and in-
tranuclear targeting steps. A similar 
 
SKY1
 
-dependent ef-
fect was also seen, although less pronounced, with ASF/
SF2, U1-70K, and U2AF65, but was not evident with
U2AF35. These observations provide an explanation for
the decreased interaction between U2AF65 and U2AF35
in 
 
sky1
 
D
 
 yeast in the two-hybrid assay. The U2AF65 fu-
sion protein expressed from the bait vector in 
 
sky1
 
D
 
 yeast
could not efficiently locate its target and activate tran-
scription of the reporter gene, even though targeting of
U2AF35 was unaffected by phosphorylation. Based on
these results, we conclude that phosphorylation plays a di-
rect role in the molecular targeting of RS domain–contain-
ing proteins within the nucleus.
 
Discussion
 
In this report, we have taken advantage of the fact that ap-
parently only one SR protein–specific kinase is conserved
in the relatively simple eukaryote 
 
S
 
.
 
 cerevisiae
 
. Therefore,
we were able to address the functional requirements of SR
protein–specific kinases in mediating SR protein–protein
interactions in vivo. An equivalent kinase deletion experi-
ment cannot be done in mammalian cells due to the pres-
ence of at least four identified kinase activities capable of
phosphorylating RS domain–containing proteins (for re-
views see Fu, 1995; Misteli and Spector, 1997). The yeast
model system is especially attractive due to the fact that
many aspects of RNA metabolism and fundamental mech-
anisms of nuclear import/export are well conserved be-
tween mammalian cells and yeast. For example, this model
organism was used successfully to address HIV rev func-
tion in mediating specific RNA transport in yeast, al-
though yeast is not a natural host for this virus (Stutz and
Rosbash, 1994; Stutz et al., 1995). Furthermore, the two-
hybrid protein–protein interaction and transcriptional re-
 
Table II. RS Domain Phosphorylation Influences In Vivo 
Interactions Mediated by Non-RS Domains
 
SKY1/sky1D U2AF35 U2AF35DRS
U2AF65 124/3 308/93
U2AF65DRS 340/8 347/460
Two-hybrid analysis of U2AF65-35 interactions in wild-type and sky1D yeast. Baits
are listed on the left and preys are listed across. Quantitative assays are expressed as
fold over background using the empty prey vector in wild-type versus sky1D strains.
Figure 5. Phosphorylation mediates molecular targeting of RS
domain proteins. Transcriptional repression assays using LexA
fusion proteins performed in wild-type and sky1D yeast. Various
bait plasmids were cotransformed with the reporter pJK101 (dia-
grammed above). Degree of reporter expression is shown as the
percentage of maximal transcription achieved without LexA.Yeakley et al. Kinase-dependent Splicing Factor Trafficking 453
pression assays have been used widely to address the func-
tion of mammalian proteins in yeast, and often accurately
reflect interactions that occur normally in mammalian
cells. Our current findings illustrate multiple steps at
which the SR superfamily of splicing factors may be regu-
lated by phosphorylation and our data are consistent with
published observations on the effects of phosphorylation
and dephosphorylation on SR proteins in mammalian cells
(see below). Although a phosphorylation-dependent nu-
clear localization defect was observed using mammalian
SC35 expressed in yeast, a similar phenomenon also oc-
curs with an endogenous Sky1p substrate, Npl3p (Yun,
C.Y., and X.-D. Fu, manuscript submitted for publication),
indicating that conserved regulatory mechanisms may op-
erate in both yeast and mammalian cells. Most advanta-
geously, the use of yeast has made it possible to provide
quantitative measures of intracellular trafficking of SR
proteins, which have been largely descriptive in previous
studies.
Nuclear Import of SR Proteins
Our localization studies showed increased cytoplasmic ac-
cumulation of SR proteins in the absence of SRPK-medi-
ated phosphorylation. The nuclear localization signal for
SC35 appears to be confined to its RS domain (Cáceres et al.,
1997), and, therefore, the effect of SRPK-mediated phos-
phorylation on SC35 localization may be readily detect-
able. In contrast, sequences both inside and outside of the
RS domain of ASF/SF2 seem to be required for the pro-
tein to properly localize in the nucleus (Cáceres et al.,
1997), and, as a result, nuclear import of ASF/SF2 may be
less efficient but not abolished without SRPK-mediated
phosphorylation. This possibility is consistent with the ob-
servations that ASF/SF2 mutants, including ASF/SF2-KS
and RS domain–deleted ASF/SF2 (Misteli et al., 1998),
were localized in both the cytoplasm and the nucleus of
transfected HeLa cells. Together, these results suggest
that the localization of different SR proteins may be dif-
ferentially facilitated by phosphorylation, which may re-
flect distinct mechanisms for their nuclear import.
Increased cytoplasmic localization of hypophosphory-
lated SR proteins may be due to inefficient nuclear import
or accelerated export. Recently, it was reported that over-
expression of Clk/Sty or SRPK2 in mammalian cells in-
creases cytoplasmic localization of ASF/SF2 (Cáceres et al.,
1998; Kuroyanagi et al., 1998; our unpublished observa-
tions), indicating that SR protein–specific kinases may
play an active role in facilitating nuclear export of SR pro-
teins. Alternatively, the dissolution of nuclear speckles by
these kinases elevates the nucleoplasmic pool of SR pro-
teins, which may indirectly lead to an increase in detect-
able cytoplasmic protein levels, as previously suggested
(Cáceres et al., 1998). In either case, the observation that
over-phosphorylation appears to stimulate SR protein ex-
port is incompatible with the idea that the lack of phos-
phorylation also accelerates nuclear export of SC35 in
sky1D yeast. Therefore, we favor the interpretation that
SKY1-mediated phosphorylation functions at the nuclear
import step, which provides a rationale for our earlier
findings that all SRPK family members from yeast to hu-
mans are largely, but not exclusively, localized in the cyto-
plasm (Takeuchi and Yanagida, 1993; Wang et al., 1998;
Siebel et al., 1999). Together, these observations suggest
that SRPKs may catalyze phosphorylation of their sub-
strates in the cytoplasm and facilitate their nuclear im-
port.
Molecular Targeting to Nascent Transcripts
In yeast, we observed that unphosphorylated SR proteins
appear to distribute uniformly in the nucleoplasm, yet
their efficient targeting to appropriate molecular targets
(in this case, the LexA binding site) requires phosphoryla-
tion mediated by Sky1p. These data are consistent with the
recent report on phosphorylation-dependent recruitment
of SR proteins to nascent transcripts (Misteli et al., 1998).
In addition, the transcriptional repression assay provided a
quantitative measure of recruitment, and, therefore, al-
lowed the comparison of different RS domain–containing
splicing factors. For example, we observed that targeting
of the SC35 fusion protein is more dependent on phosphor-
ylation than that of ASF/SF2 and other RS domain–con-
taining splicing factors, which may result from the phos-
phorylation dependence of SC35 for both efficient nuclear
import and intranuclear movement. The mechanism for
phosphorylation-dependent targeting is not entirely clear,
but may be explained by the possibility that an unphos-
phorylated RS domain may interact with other nuclear
constituents. For example, it was suggested, based on in
vitro experiments, that phosphorylation is necessary for
sequence-specific binding of SR proteins to their RNA
targets (Tacke et al., 1997; Xiao and Manley, 1997).
In addition to increasing protein–nucleic acid binding
specificity, phosphorylation can modulate protein–protein
interactions among RS domains in vitro (Xiao and Man-
ley, 1997; Wang et al., 1998). Our finding that phosphory-
lation increases ASF/SF2-U1-70K interactions, but has lit-
tle effect on ASF/SF2-U2AF35 interactions, suggests that
phosphorylation can differentially modulate protein–pro-
tein interactions depending on the protein pairs. There-
fore, phosphorylation may regulate molecular targeting of
RS domain–containing proteins to their appropriate pro-
tein partners after being recruited to actively transcribing
regions in the nucleus. This phosphorylation-dependent
selectivity may be crucial for an orderly assembly of splic-
ing factors on specific transcripts at specific stages of the
splicing reaction.
Dynamic Distribution of Splicing Factors in
the Nucleus
In mammalian cells, splicing factors are believed to be
“stored” in nuclear speckles (for reviews, see Spector,
1993; Singer and Green, 1997) and recruited to nascent
transcripts to carry out the splicing reaction. The exchange
of SR proteins between the nucleoplasm and nuclear
speckles is highly dynamic, as illustrated by monitoring the
movement of GFP-ASF/SF2 in living cells (Misteli et al.,
1997, 1998). Earlier studies have shown that increased
phosphorylation releases SR proteins to the nucleoplasm
(Gui et al., 1994a; Colwill et al., 1996a; Misteli et al., 1997;
Duncan et al., 1998; Wang et al., 1998), making them gen-
erally available to be recruited to the sites of transcription
and splicing, whereas dephosphorylation appears to be es-The Journal of Cell Biology, Volume 145, 1999 454
sential for the resolution of spliceosomes (Mermoud et al.,
1994), and as a result, contributes to the accumulation of
SR proteins in nuclear speckles (Misteli and Spector,
1997). In the current study, SR proteins in sky1D yeast re-
mained soluble, suggesting that unphosphorylated SR pro-
teins may not form nonspecific aggregates resembling in-
clusion bodies in yeast, yet they do not interact with each
other efficiently. Interestingly, we observed that removal
of the RS domains from both U2AF65 and U2AF35 al-
lowed them to interact very efficiently in both wild-type
and sky1D yeast, even better than the interaction between
the full-length proteins in wild-type yeast. This result im-
plies that even in wild-type cells, some proteins may not be
sufficiently phosphorylated for efficient interaction. Be-
cause we detect U2AF65/35 in large complexes in both
wild-type and sky1D yeast, it is possible that phosphory-
lated and unphosphorylated proteins may interact with
different sets of proteins.
In fact, interactions involving hypophosphorylated RS
domain–containing splicing factors may resemble those in
nuclear speckles where a series of rearranged protein–pro-
tein and protein–RNA interactions have been triggered by
phosphatases during splicing. To some extent, these de-
phosphorylation-induced rearrangements may cause the
coalescence of splicing complexes on nascent transcripts to
give rise to the appearance of speckles in the nucleus.
Therefore, one might imagine that nuclear speckles are
postsplicing structures for recycling of splicing factors,
rather than storage sites where splicing factors are ran-
domly accumulated. This scenario may best explain the
observations that nuclear speckles contain essentially all
splicing factors as well as poly (A)1 mRNA (Xing et al.,
1993, 1995), but are not sites for the majority of nascent
transcripts detected by BrUTP pulse labeling (Jackson et
al., 1993).
A Model for Phosphorylation-dependent Movement of 
Splicing Factors in Cells
A synthesis of our results with published reports is pre-
sented in a model (Fig. 6), depicting the dependence of SR
protein trafficking on phosphorylation. In this model,
nuclear import of newly translated or shuttling RS do-
main–containing proteins is facilitated by phosphoryla-
tion. Newly imported SR proteins are then partitioned be-
tween speckles and the nucleoplasm based in part on the
extent of phosphorylation. A large body of evidence sug-
gests that mRNA splicing takes place cotranscriptionally
in the nucleoplasm whereas nuclear speckles have been
described as “storage sites” for splicing factors. Release of
SR proteins from speckles is facilitated by phosphoryla-
tion (Gui et al., 1994a; Colwill et al., 1996a), which is a pre-
requisite for their subsequent recruitment to nascent tran-
scripts (Misteli et al., 1998). We show in the current study
that specific targeting of nucleoplasmic SR proteins to
their appropriate RNA and protein partners are also af-
fected by phosphorylation. Once assembled on nascent
transcripts, the resolution of splicing complexes during the
splicing reaction appears to require dephosphorylation of
SR proteins (Mermoud et al., 1994), which may accom-
pany a series of rearrangements involving both RNAs and
proteins in the spliceosome. As a result, hypophosphory-
lated SR proteins may be engaged in interactions with a
distinct set of proteins, causing them to remain in speckles,
as mature transcripts proceed to nuclear export.
In summary, the novel system developed in this study
enabled us to dissect this complex process in a relatively
simple genetic background. The data presented in this re-
port illustrate that SR protein kinases can affect transloca-
tion of RS domain–containing proteins from the cyto-
plasm to the nucleus as well as molecular targeting within
the nucleus, in addition to modulation of RS domain affin-
ities observed in vitro. Defects in combinations of these
processes provide a probable explanation for the critical
dependence of RS domain interactions on SRPK-medi-
ated phosphorylation in cells. These phosphorylation-
dependent steps provide multiple avenues for pre-mRNA
splicing regulation in response to internal or external sig-
naling.
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